Delivery Order SPE2DB22D3004-SPE2DB24FPE86
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of EMERPHED 25 MG/5 ML SYRINGE 5ML pharmaceutical products. The $2,612.11 contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp, a for-profit company, serves as the prime contractor and is not utilizing any set-aside designations. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FPX06) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML pharmaceutical products. The $1,312.12 delivery order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,298,256 units of the pharmaceutical product EMERPHED 25 MG/5 ML SYRINGE 5ML. The $2,040.20 delivery order has a completion date of January 11, 2024 and was awarded on January 10, 2024. Amerisourcebergen Drug Corp has previously received multiple federal contract awards from DLA Troop Support...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for EMERPHED 50 mg/10 mL vials with a ceiling value of $1,390.95 and a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order, with ultimate completion scheduled for August 11, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the pharmaceutical...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,470.43 firm fixed-price delivery order is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price, valued at $2,834.82, and has an ultimate completion date of January 17, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product, with a completion date of March 21, 2024 and a ceiling value of $2,501.34. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
- The Defense Logistics Agency awarded a $2,168.54 delivery order to AmerisourceBergen Drug Corp for EMERPHED 25 MG/5 ML syringes (5 ML) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The firm fixed-price delivery order, valued at $1,640.15, has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to supply a wide range of medical commodities,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPE86Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a potential value of $1,968.18 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This order is placed under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to supply pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 2/2/24 |